Representation of patients with a migration background in studies on antithrombotic treatment. An analysis of recruitment data from a cluster randomized controlled trial

The health status, health awareness and health behavior of persons with a migration background often differ from the autochthonous population. Little is known about the proportion of patients with a migration background (PMB) that participate in primary care studies on oral antithrombotic treatment...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2020-03, Vol.15 (3), p.e0230297-e0230297
Main Authors: Mergenthal, Karola, Siebenhofer, Andrea, Ulrich, Lisa-R, Guethlin, Corina, Gerlach, Ferdinand M, Petersen, Juliana J
Format: Article
Language:English
Subjects:
Analysis
Anticoagulants
Biology and Life Sciences
Bivariate analysis
Cardiac arrhythmia
Case management
Clinical trials
Clusters
Computer industry
Dementia
Gender
German language
Health
Health behavior
Health care
Health services
Heterogeneity
Language
Language skills
Medical research
Medicine and Health Sciences
Participation
Patients
People and places
Population
Primary care
Randomization
Social Sciences
Sociodemographics
Statistical analysis
Studies
Substance abuse treatment
Thromboembolism
Warfarin
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The health status, health awareness and health behavior of persons with a migration background often differ from the autochthonous population. Little is known about the proportion of patients with a migration background (PMB) that participate in primary care studies on oral antithrombotic treatment (OAT) in Germany, and whether the quality of their antithrombotic care differs from patients without a migration background. The aim of this paper was to use the results of a cluster-randomized controlled trial (PICANT) to determine the proportion of PMB at different stages of recruitment, and to compare the results in terms of sociodemographic characteristics and antithrombotic treatment. This study used screening and baseline data from the PICANT trial on oral anticoagulation management in GP practices. For this analysis, we determined the proportion of PMB during the recruitment period at stage 1 (screening of potentially eligible patients), stage 2 (eligible patients invited to participate in the trial), and stage 3 (assessment of baseline characteristics of patients participating in the PICANT trial). In addition, we compared patients in terms of sociodemographic characteristics and quality of anticoagulant treatment. Statistical analysis comprised descriptive and bivariate analyses. The proportion of PMB at each recruitment stage declined from 9.1% at stage 1 to 7.9% at stage 2 and 7.3% at stage 3). A lack of German language skills led to the exclusion of half the otherwise eligible PMB. At stages 1 and 3, PMB were younger (stage 1: 70.7 vs. 75.0 years, p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0230297